BioRestorative Therapies, Inc.
(NASDAQ:BRTX)
$1.90
-0.03 (-1.55%)
At Close: 4:00 PM
BRTX Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
BRTX Stock Price Today
BioRestorative Therapies, Inc. (BRTX) stock declined over -2.56% intraday to trade at $1.9 a share on NASDAQ. The stock opened with a loss of 0.00% at $1.95 and touched an intraday high of $2.01, falling -2.56% against the last close of $1.95. The BioRestorative Therapies, Inc. in stock market went to a low of $1.88 during the session.
BRTX Stock Snapshot
$1.95
Prev. Close
8.95 Million
Market Cap
$1.88
Day Low
$1.95
Open
4.71 Million
Number of Shares
$2.01
Day High
N/A
P/E ratio
-4.12
EPS (TTM)
2.60
Cash Flow per Share
N/A
Free Float in %
2.74
Book Value
29095.00
Volume
BRTX Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
Employees10.00
Beta58.35
Sales or Revenue$130.2 Thousands
5Y Sales Change26.71%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.
Peers
Frequently Asked Questions
What is the current BioRestorative Therapies, Inc. (BRTX) stock price?
BioRestorative Therapies, Inc. (NASDAQ: BRTX) stock price is $1.90 in the last trading session. During the trading session, BRTX stock reached the peak price of $2.01 while $1.88 was the lowest point it dropped to. The percentage change in BRTX stock occurred in the recent session was -2.56% while the dollar amount for the price change in BRTX stock was -$0.05.
BRTX's industry and sector of operation?
The NASDAQ listed BRTX is part of Biotechnology industry that operates in the broader Healthcare sector. BioRestorative Therapies, Inc. , a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells.
Who are the executives of BRTX?
Mr. Lance Alstodt
Chairman, Pres & Chief Executive Officer
Mr. Francisco J. Silva
Chief Scientist, Vice President of R&D, Sec. and Director
Mr. Lance Alstodt
Chairman, Pres & CEO
Mr. Francisco J. Silva
Chief Scientist, VP of R&D, Sec. and Director
How BRTX did perform over past 52-week?
BRTX's closing price is 0.67% higher than its 52-week low of $1.405 where as its distance from 52-week high of $7.13 is -0.18%.
How many employees does BRTX have?
Number of BRTX employees currently stands at 10.00. BRTX operates from 40 Marcus Drive, Melville, NY 11747, US.
Link for BRTX official website?
Official Website of BRTX is: https://www.biorestorative.com
How do I contact BRTX?
BRTX could be contacted at phone #631 760 8100 and can also be accessed through its website. BRTX operates from 40 Marcus Drive, Melville, NY 11747, US.
How many shares of BRTX are traded daily?
BRTX stock volume for the day was 29095.00 shares. The average number of BRTX shares traded daily for last 3 months was 33.99 Thousands.
What is the market cap of BRTX currently?
The market value of BRTX currently stands at $8.95 Million with its latest stock price at $1.90 and 4.71 Million of its shares outstanding.